The $1.3 million IOM review will be asking whether the current clearance process protects patients and promote innovation, and, if not, whether any legislative, regulatory or administrative changes are needed.
The IOM will hold two public workshops on the matter in the next nine months and publish a final report in March 2011.
Read the FDA’s release on its medical device clearance process.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
